Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor

被引:331
作者
Rauch, U
Bonderman, D
Bohrmann, B
Badimon, JJ
Himber, J
Riederer, MA
Nemerson, Y
机构
[1] CUNY Mt Sinai Sch Med, Div Thrombosis Res, Dept Med, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
[3] F Hoffmann La Roche & Co Ltd, Div Pharma, Preclin Res, CH-4002 Basel, Switzerland
关键词
D O I
10.1182/blood.V96.1.170.013k42_170_175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe thrombogenic tissue factor (TF) on leukocyte-derived microparticles and their incorporation into spontaneous human thrombi. Polymorphonuclear leukocytes and monocytes transfer TF+ particles to platelets, thereby making them capable of triggering and propagating thrombosis. This phenomenon calls into question the original dogma that vessel wall injury and exposure of TF within the vasculature to blood is sufficient for the occurrence of arterial thrombosis. The transfer of TF+ leukocyte-derived particles is dependent on the interaction of CD15 and TF with platelets. Both the inhibition of TF transfer to platelets by antagonizing the interaction CD15 with P-selectin and the direct inter action of TF itself suggest a novel therapeutic approach to prevent thrombosis. (Blood. 2000;96:170-175) (C) 2000 by The American Society of Hematology.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 36 条